European Union · Question · QUESTION_WRITTEN
E-10-2025-002214
Reassessment of the EU’s COVID-19 vaccine authorisation in the light of long-term effectiveness and international policy developments, particularly in the United States
Introduced
3 June 2025
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 August 2025
Records
Official question E-10-2025-002214 from European Union at European Parliament. Dated 3 June 2025. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Reassessment of the EU’s COVID-19 vaccine authorisation in the light of long-term effectiveness and international policy developments, particularly in the United States
Reassessment of the EU’s COVID-19 vaccine authorisation in the light of long-term effectiveness and international policy developments, particularly in the United States
QUESTION_WRITTEN · EN · 13 June 2025
Reassessment of the EU’s COVID-19 vaccine authorisation in the light of long-term effectiveness and international policy developments, particularly in the United States
QUESTION_WRITTEN · EN · 13 June 2025
Answer
QUESTION_WRITTEN_ANSWER · 20 August 2025
Neubewertung der EU-Zulassung für COVID-19-Impfstoffe angesichts der langfristigen Wirksamkeit und der internationalen politischen Entwicklungen, insbesondere in den USA
QUESTION_WRITTEN · DE · 13 June 2025
Neubewertung der EU-Zulassung für COVID-19-Impfstoffe angesichts der langfristigen Wirksamkeit und der internationalen politischen Entwicklungen, insbesondere in den USA
QUESTION_WRITTEN · DE · 13 June 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.